WASHINGTON, D.C. (Feb. 8, 1999) Among the investor sessions featured at the Biotechnology Industry Organization's (BIO) annual CEO & Investor Conference in New York, Feb. 24-26, is a program on "Vaccines and Women's Health Issues."
The session will highlight the latest advances in drugs and vaccines for treatment of diseases that strike women the most, such as lupus and breast, ovarian and cervical cancers. Companies participating in the session are Biomira Inc., Corixa Corp., La Jolla Pharmaceuticals and StressGen Biotechnologies Corp.
BIO's CEO & Investor Conference is different from most biotech investment conferences. Company presentations are grouped by disease or technology approach and CEOs will participate in roundtable discussions on a variety of business issues.
Other investor sessions will focus on cancer as well as the most advanced treatments for rheumatoid arthritis, cardiovascular diseases, infectious diseases and central nervous system disorders.
The conference will be held at the New York Palace Hotel. News media should contact Charles Craig (202-962-9200) to register.